Michael J. Mauro MD

Michael J. Mauro, MD, directs the Myeloproliferative Neoplasms (MPN) Program at the Memorial Sloan-Kettering Cancer Center in New York. He received his medical degree from Dartmouth Medical School and completed his residency and fellowship training at New York-Presbyterian Hospital/Weill Cornell Medical Center.

For more than a decade, he worked with Dr. Brian Druker at the OHSU Knight Cancer Institute in Portland, Oregon, with a focus on research in CML. There, he directed the CML clinical trial program and was involved in the early development and sentinel clinical study of targeted therapy for CML. His clinical focus is in CML with interest in therapy optimization, novel therapies, treatment-free remission, and pregnancy/fertility, as well as other myeloproliferative neoplasms, including myelofibrosis, polycythemia, and thrombocytosis, and less common conditions such as eosinophillic and mast cell disorders.